Anti-VEGFR2 (Phospho-Tyr951) Antibody
如果您對(duì)該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱(chēng): Anti-VEGFR2 (Phospho-Tyr951) Antibody
產(chǎn)品型號(hào):
產(chǎn)品展商: 其他品牌
產(chǎn)品文檔: 無(wú)相關(guān)文檔
簡(jiǎn)單介紹
Anti-VEGFR2 (Phospho-Tyr951) Antibody
的詳細(xì)介紹
| Overview |
Print Version
|
| Product Name |
Anti-VEGFR2 (Phospho-Tyr951) Antibody |
| Subtype |
polyclonal |
| Application |
WB, IHC |
| Raised In |
rabbit |
| Specificity |
VEGFR2 (phospho-Tyr951) antibody detects endogenous levels of VEGFR2 only when
phosphorylated at tyrosine 951. |
| Immunogen |
The antiserum was produced against synthesized phosphopeptide derived from human
VEGFR2 around the phosphorylation site of tyrosine 951 (K-D-YP-V-G). |
| Guarantee |
abm guarantees that all our Anti-VEGFR2 (Phospho-Tyr951) Antibody will perform as described on this product webpage, if this is not the case we will provide you with a one-time replacement at no extra cost. Documentation and explanation of experiment conducted will be required when submitting a claim for replacement. |
| Properties |
|
| Formulation |
Liquid |
| Quantity |
100 μg |
| Clone |
N/A |
| Storage |
This product is stable for several weeks at 4°C as an undiluted liquid. Dilute only prior to immediate use. For extended storage, aliquot contents and freeze at -20°C or below. Avoid cycles of freezing and thawing. Expiration date is one (1) year from date of receipt. |
| Storage Buffer |
phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
| Concentration |
1μg/ul |
| Purity |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using
epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed
by chromatogramphy using non-phosphopeptide corresponding to the phosphorylation site. |
| Species Reactivity |
human, mouse, rat |
| Anti-VEGFR2 (Phospho-Tyr951) Antibody Images |
|
| Specific References |
|
Y011086 has been referenced in 1 publication.
-
Zeng H, et al. (2001) J Biol Chem. 276(35): 32714-32719.
Dougher M, et al. (1999) Oncogene. 18(8): 1619-1627.
|
